View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Genitrix has launched Dentagen toothpaste which, the company says, uniquely both cleans teeth and inhibits the formation of plaque.
Dentagen toothpaste is based on RF2, a plant extract, which is clinically proven to inhibit the formation of dental biofilm or plaque. It has been formulated to a dentrifrice abrasivity (RDA) index of 34 to ensure that it removes plaque while causing no damage to the enamel layer of the teeth. The toothpaste is packaged with a free finger-brush to help introduce the pet to having its teeth brushed. It costs £5.50 for a 70g tube.
The toothpaste completes the range of Dentagen health products - the fastest growing dental products in the UK (according to GFK data in May 2010).
Genitrix says Dentagen is the only veterinary dental system to combine a procedure carried out in practice with a variety of aftercare regimes to ensure owner compliance. In 2008, Genitrix launched the Dentagen plaque protection system. It consists of a RF2-impregnated wax provided to practices in a syringe and applied to the gingival layer and the buccal area of teeth of dogs or cats at the end of dental procedures. Pet owners then maintain the protective coating by using the new Dentagen toothpaste or other products in the range - either the RF2-impregnated vegetable-based palatable Dentagen chews or Dentagen Aqua, a palatable liquid containing RF2, which is added to a pet's drinking water on a daily basis.
Rob Watkins, Genitrix' Marketing Director, said: "Brushing has long been recognised as the 'gold standard' when it comes to dental health care so we felt it was important for the Dentagen range to include this option. Regular brushing makes a significant contribution to the maintenance of oral health and the RF2 in the Dentagen toothpaste actually suppresses plaque formation between brushing which is a further benefit. It sets a new efficacy standard for pet toothpaste.
However, while many owners understand the importance of dental health, many of them find actually brushing their pet's teeth difficult - especially those with cats. This is why the Dentagen range includes a variety of options. It enables pet owners to select the method that is right for them and their pet and thus maximise the likelihood of their compliance with a good preventive health regime."
Boehringer Ingelheim is offering a free stainless steel bolus applicators, worth £42.60/€ 59.39 (plus VAT), with the first 1,000 Bovikalc multipacks sold after 1st March in the UK and Eire.
According to the company, milk fever is recognised as the most common mineral deficiency affecting transition cows; one that has a significant impact on the overall health of affected animals, even those showing no outward symptoms. This offer aims to help combat this costly but preventable disease.
The offer is open to farmers, vets and suppliers of Bovikalc and one free applicator will be provided for each Bovikalc multipack - 6 x 4 boluses.
Farmers are required to apply for the free applicators through their veterinary surgeon or Bovikalc supplier.
For further information, including the terms and conditions of the offer, visit www.bovikalc.co.uk. Alternatively, contact your regional cattle specialist or call Boehringer on 01344 746959.
The RCVS has announced the results of the RCVS Council and VN Council elections.
Re-elected to three of the six seats available on RCVS Council were current President Neil Smith (1,687 votes), incoming Standards Committee Chairman David Catlow (1,656) and Vice-President Jacqui Molyneux (1,304); and, from RCVS Day on 11 July 2014, they will be joined by new members David Bartram (1,674), Susan Paterson (1,496) and Mandisa Greene (1,296).
The two available places on VN Council were taken by existing member Hilary Orpet (611 votes) and new member Amber Richards (371).
Notably, half of the successful RCVS Council candidates this year were women, two of whom being elected for the first time.
Overall turnouts in both elections fell, with 4,137 (16.1%) veterinary surgeons and 1,157 (10%) veterinary nurses voting. These turnouts and voter numbers compare with 4,661 (18.8%) and 1,329 (12.5%) last year, and ten-year averages of 3,927 (17.4%) and 869 (9.9%), respectively.
RCVS Registrar Gordon Hockey, said: "It was always going to be tough to beat last year's record turnout, even with a record number of candidates standing this year, but it's encouraging that voter numbers are still the third highest in the last ten years.
"I'd like to be amongst the first to publicly congratulate all the successful candidates this year, and to encourage those who weren't successful this time to stand again in the future. I'm very much looking forward to working with our three new RCVS Council members whilst, at the same time, delighted that the profession has returned three existing members to their seats, enabling them to continue their work for the College."
Chair of VN Council, Kathy Kissick, says: "Many congratulations to Hilary, who has been returned to the VN Council for the third time running, and to Amber, who I'm looking forward to welcoming to VN Council in July. Hilary's experience and Amber's fresh input will, I'm sure, combine to provide an excellent contribution to our ongoing work."
The measures agreed by RCVS Council will allow UK-practising members to spread the cost of renewal over three instalments: paying 50% of the full cost by 30th April, 25% by 30th September, and the remaining 25% by 31st December.
Kit Sturgess, Treasurer, said: “We recognise that most veterinary businesses will be seeing a downtown during the coronavirus (COVID-19) lockdown, especially as veterinary practices reduce their workloads to emergency-only procedures or those that can be classed as urgent. Furthermore, we understand that many individual veterinary surgeons will no longer be working, and that this will cause financial difficulties for many vets and their families.
"We appreciate that this is a very difficult time for the profession, and as part of our compassionate approach to regulation we wanted to do our bit to help people manage the difficult financial consequences of the coronavirus crisis, and to help them to return to work as soon as Government advice allows. While fees for veterinary nurses are not due until the end of the year, we will keep the impact of the coronavirus pandemic under review on an ongoing basis.”
Any UK-practising member wishing to switch to the payment-by-instalments system should cancel their existing Direct Debits immediately (the College has already temporarily deferred these direct debits for around 10-14 days to allow time for them to be cancelled).
The College says that any member who does not pay the first instalment of 50% of the total fee by the end of April will need to pay the full amount in one instalment by the end of May. Should they then fail to make this payment, the College would then have to remove their name from the Register.
Those who pay the initial 50% instalment but fail to pay one or both of the subsequent 25% instalments will be moved to the non-practising Register for up to one year. This would mean that they could transfer back to the UK-practising Register without incurring a restoration fee. However, they would no longer legally be entitled to practise as a veterinary surgeon while on the non-practising Register until they had paid the retention fee in full and been transferred back to the UK-practising Register.
RCVS Council also agreed that the higher fee that usually applies for late payments, ie those made between 1 May and 30 May, will not be applied to any category of membership this year.
Members can opt to move to the new arrangements or continue with full payment. Details of how to pay under the new arrangements will be sent to members shortly. Any member who has already paid their fee in full and would like to switch to the payment-by-instalments mechanism should contact the College on refunds@rcvs.org.uk.
Further details about the scheme are available in a detailed Frequently Asked Questions guide via www.rcvs.org.uk/coronavirus.
COMMENTIt has been argued that at a time when many veterinary surgeons have lost a significant part of their livelihood, the College should have gone further and reduced the renewal fees, at least for the period of time that vets' earning ability is compromised. I'm not qualified to judge whether the College could have afforded that, and a spokesman would only say: "...we have to work within the framework of the legislation and the statutory instrument and, given this, the measures that RCVS Council has put in place is a reasonable outcome and will assist veterinary surgeons who may be struggling during these very tough times."
New graduates will work through both programmes during their first two years in practice.
Linnaeus says the GDP will continue to focus on support and networking, giving access to mentors, social events and a structured education programme that covers 12 educational days.
The GDP will cover primary care skills development and things like veterinary business training, leadership skills and time management.
All graduates will then complete the ECP, which is designed to offer greater flexibility as the participants start to focus on different clinical areas.
Professional and clinical skills training will be more tailored to graduates’ topics of interest, and funding will be available to cover the cost of CPD courses that support individual areas of development.
Professor Séverine Tasker, Chief Medical Officer at Linnaeus (pictured right), said: "We decided to update the GDP after asking for feedback from across Linnaeus and our stakeholders.
“While many graduates need a lot of guidance in the first 12 months of their veterinary careers, they will then start to develop more specific areas of interest.
"By developing two separate programmes, we can offer education, guidance, networking and flexibility that is adapted to the progression of our graduates.”
The next Linnaeus GDP starts in the summer of 2022 and is open for applications from now until the end of May.
The ECP provision will be available from mid-2022 to support recent graduates that join Linnaeus outside of their GDP intake.
For more information, visit www.linnaeusgroup.co.uk/careers/graduates-students-and-apprenticeships.
The increase, which was approved by the Privy Council on Thursday 2 March, will mean that the standard annual renewal fee for UK-practising veterinary surgeons (which must be paid on or before 1 April 2023) will increase by £15 to £379.
The full list of RCVS fees can be found at www.rcvs.org.uk/how-we-work/fees
Lizzie Lockett, RCVS CEO, said: “We are proud that all throughout the pandemic period, when we know that many were struggling, we managed to keep our fees at the same level in the 2020/21, 2021/22, and 2022/23 fee years.
“The increase that we proposed to the Privy Council is very modest, particularly in comparison to the overall levels of inflation that the British economy has experienced over the past year, which has had an impact on our costs.
“While we appreciate that any rise in fee levels will not be welcomed by everyone, we can assure all members of the professions that we are continuing to use our income prudently and with oversight from our Audit & Risk and Finance & Resources Committees.”
As the increase has been confirmed by the Privy Council, annual renewal fee notifications will be sent to all veterinary surgeons in early March.
Dechra Veterinary Products is offering CPD sessions as podcasts for the first time, as part of a new series of presentations on canine hyperadrenocorticism.
The Cushing's Challenge series, which will also be available as webcasts with supporting notes, is designed to challenge vets to update their knowledge on the syndrome.
There will be six presentations released on the company's online learning resource, The Dechra Academy, starting this month.
Dechra Veterinary Products Brand Manager, Craig Sankey said: "Although Cushing's is a common canine endocrinopathy, it can be challenging to diagnose and can mimic non-adrenal disorders. Test results can also sometimes be inconclusive which is why we've developed this series of CPD sessions to support veterinary professionals who want to update their knowledge.
"The Cushing's Challenge series will be the first time Dechra has used podcasts to deliver CPD, which can be downloaded and listened to on any MP3 player. They can also be viewed on a PC or tablet as a webcast with each of the presentations varying in length, from around 12 to 25 minutes long. By offering the presentations in both of these formats, we are able to offer flexible support to help busy veterinary professionals with CPD.
"The first episodes will focus on pathophysiology, clinical signs and routine lab tests with successive presentations released in the coming weeks. The next two in the series will cover diagnostic tests and then differentiation tests."
CPD certificates will be available at the end of the series via email.
The free-of-charge CPD is accompanied by client support materials for practices as part of Dechra's new Vetoryl campaign.
The Cushing's Challenge CPD is available at www.dechra.co.uk/academy,
The British Association of Veterinary Emergency & Critical Care has released the results of a survey into practitioners attitudes to 24-7 and OOH home visits.
360 veterinary surgeons took part in the survey, nearly all of whom have been practising for more than 2 years. 70% work in small animal practice, 12% at a dedicated OOH provider, and the bulk of the remainder in referral or mixed practice. 81% described the work they do as small animal first opinion, and 76% were employees. 35% said they had already responded to the RCVS call for evidence on the provision of 24/7 emergency cover.
26% said they work for a practice that outsources its OOH to a dedicated provider, and more than 85% of those said they would not return to an on-call system.
In terms of dedicated out-of-hours providers, a clear pattern emerged. Namely those practitioners who outsource their OOH feel that patient care, staff safety and professional well-being are all enhanced by dedicated OOH services, but that dedicated OOH comes at a cost of reduced value for money for the pet owner. Customer service between the different OOH provisions is perceived to be similar (on-call better 25%, same 48%, and dedicated better 27%).
Among those practitioners who work for a dedicated OOH service, dedicated OOH services perform best in all categories. 68% responded that OOH customer service is better with a dedicated OOH service compared to an on-call system (12% responded that on-call provided better customer service on average). 44% responded that customer value for money was better with dedicated OOH service compared to 19% who responded that customer value for money was on average better with an on-call system.
Among those practitioners who do their own on-call, customer service and value for money were perceived to be better with an on-call system (42% v 26% and 61% v 15% respectively). In the other categories dedicated OOH services again out-performed an on-call system.
Whether routine or emergency, 'owner demands' were felt to be the biggest reason for home visit requests (41% and 30% respectively). However, 'genuine clinical need' was the main reason cited by 19% of respondents as the main reason for emergency home visits. Inability to move the animal was given as the main reason by a further 28%.
Participants in the survey were asked to score (out of 10) how much their decision to perform a home visit was affected by the threat of a complaint, either to their employer or to the RCVS. Interestingly, 37% said a complaint to their employer weighed heavily on the decision (ranking it 8 or higher) where, by comparison, 52% said the threat of a complaint to the College ranked 8 or higher in their decision making.
69% of respondents said they make visits alone, either sometimes or always. When asked if they had ever felt threatened whilst performing an OOH visit, 48% said yes. This compared to 23% who said that they had felt threatened when performing a visit in normal hours.
When asked to rank (out of 10) the stress home visits cause, 7% said none at all and 36% said 8 or above.
72% said they believe that the profession should continue to be obligated to provide 24/7 for animals.
Respondents were then asked to say whether they support or disagree with the suggestion that the need to perform house visits is removed from the CoPC. 59% were strongly for the idea (scoring it up to 3), compared to 22% who were strongly against it (scoring it 8 or above).
Opinions about whether the College should clarify the need to perform house visits was far more clear cut. 77% strongly supported clarification (scored up to 3), whereas only 16% said there was no need (scored 8 or above).
However, an overwhelming 93% said that they would continue to perform visits in the case of genuine clinical need even if the Code of Professional Conduct was changed to make it dear that there was no risk of disciplinary action for not attending off-site.
The annual minimum requirement for vets will be reduced from 35 to 26 hours of CPD, while that of veterinary nurses will be reduced from 15 to 11 hours. The reduction comes into force immediately.
A similar 25% reduction will also be introduced for veterinary surgeons holding Advanced Practitioner or RCVS Specialist status.
The decision to reduce the hours was made by the new RCVS Council COVID-19 Taskforce, chaired by RCVS President Dr Niall Connell, which was set up in order to make temporary policy decisions related to the pandemic in a quicker and more agile way. The proposal had previously been considered and supported by the RCVS Education Committee, VN Council and CPD Policy Working Group.
Niall said: “A number of veterinary surgeons and veterinary nurses expressed concern that it may be difficult to undertake CPD at present and so, in order to give the professions some breathing space, we decided we would reduce the minimum hours required for 2020. We also recognise that some practices are having to make the difficult decision to reduce their CPD budgets this year in response to falling footfall.
"However, it is worth reiterating that CPD need not be expensive or require physical attendance at lectures, congresses or other events. There are many online providers of CPD and other resources such as articles and webinars, some of which may be free. The key is that the CPD is relevant to you and enhances your professional practice and so we would still encourage all our members to undertake CPD as and when they can."
The policy will be under regular review and may be extended further if the circumstances demand. Those with any questions on the policy change should contact the RCVS Education Department on cpd@rcvs.org.uk
A full range of FAQs on the COVID-19 pandemic and the impact on the veterinary profession are available to view at www.rcvs.org.uk/coronavirus
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
A debate held at BEVA Congress last month ended with more than 70% of voters disagreeing with the motion: this house believes that new vet schools will benefit equine veterinary practice in the UK.
The result reflects a recent industry survey indicating that up to five times as many veterinary graduates may be seeking work in equine practice as there are jobs available.
Chris Proudman, founding head of Surrey University's new School of Veterinary Medicine and Mark Bowen, Associate Professor of Veterinary Internal Medicine at the University of Nottingham's School of Veterinary Medicine and Science, advocated that new UK vet schools are important for the advancement of the profession.
Mark Bowen said: "New UK vet schools will benefit the profession by improving the standards of veterinary education and creating what the consumer wants." He argued that new schools would help improve teaching methods and clinical training, while the resultant smaller class sizes would provide greater opportunities for hands on training. Competition would also help to drive up standards and inspire other universities to instigate much-needed changes such as focusing on quality of teaching rather than research.
Chris Proudman emphasised the flexibility of a new vet school to be progressive and innovative in both curriculum design and teaching delivery. He said: "Designing a curriculum from scratch allows novel approaches to partnership working and to the One Health agenda. New schools can deliver veterinary graduates better equipped with the skills and knowledge to be the veterinary leaders of the future."
The proposers also reasoned that if school leavers cannot find a place in a UK vet school they can now attend English language veterinary schools in universities across the EU, many of which do not have European accreditation to ensure standards of education. Therefore the increase in numbers of veterinary graduates is irresistible and the authorities can only influence the numbers trained in the UK and govern the high quality of teaching that is provided in the UK.
Alastair Welch, a partner at Donnington Grove Veterinary Group in Berkshire and Lucy Grieve, vet at Darley Pre-Training in Newmarket, staunchly countered the motion. They maintained that new vet schools would have a detrimental impact on the industry over the longer term and that their introduction demonstrated a slackening of the RCVS's management of the profession.
Alastair said: "Both anecdotal and empirical data suggest that becoming a horse vet has never been harder. The seemingly endless supply of hard-working, well-qualified school leavers determined to become equine vets provides universities with a reliable income stream for years to come but at what cost? I remain to be convinced that we will not end up educating veterinary graduates who cannot find a position in their intended career."
Lucy contended that it was irresponsible and immoral to allow individuals to commit five or six years, and tens of thousands of pounds, towards a veterinary career without them first being made aware of the limited opportunities available in very popular sectors of the profession such as equine practice.
Paul Jepson, President of BEVA, said: "With more than 70% of voters opposing the motion there is clearly a discernable level of disquiet amongst BEVA members about the current job market in equine practice and the further dilution of opportunities that increased numbers of graduates will create."
To help address the growing challenges faced by new graduates BEVA has recently introduced an Internship Awareness Programme (IAP). The scheme aims to help students and vets navigate the opportunities available as an intern and helps equine veterinary practices to find the most suitable employees for their practice.
You should be able to view the debate here: http://www.fsmevents.com/beva/congress13-session34. If not, the debate can be viewed on the BEVA website by following these instructions. Click the Webinar tab. Then click register. Then complete the £0 transaction and you will be able to access the free webinars. Select 'Free sessions' (Click the + symbol). Select 'Current Affairs: New vet schools - supply and demand?'
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
Sebastian Griffin (pictured right), an advanced practitioner in small animal medicine at Vet4life in London is leading the research alongside Fabio Stabile, an expert in veterinary neurology at Southfields Veterinary Specialists in Essex, and Luisa De Risio, Clinical Research & Excellence Director at Linnaeus and a specialist in veterinary neurology.
Sebastian said: “There is so much more to learn about canine idiopathic epilepsy, to ensure that vets, pets and their owners have the best possible support when dealing with this disorder.
"We want to offer a more targeted, clinically applicable, and relevant approach to its diagnosis and treatment.
“Any vet who has recently treated dogs with idiopathic epilepsy in primary care is invited to respond.
"The survey only takes five to ten minutes but provides us with invaluable information that will help to inform and develop best practice.
"We are planning to share the results, along with educational resources and evidence-based guidelines, with our peers across the industry next year.”
The survey and further information can be found via https://bit.ly/3mfwVRe.
The study and survey results are due to be published in an open access peer-reviewed scientific journal by the end of 2022.
The survey, which is anonymous, closes on 15 January 2022.
Helen Ghosh, Defra's Permanent Secretary today confirmed the appointment of Nigel Gibbens as Chief Veterinary Officer (CVO). Nigel qualified as a veterinary surgeon in 1981 and has spent most of his career involved in animal health and welfare with lead roles on international trade and exotic diseases. Since 1990 he has held a variety of operational and advisory positions in the Government's veterinary and policy services. Nigel moved to the central animal health policy group in 1996 and worked on international trade for eight years, followed by surveillance and control of Bovine Spongiform Encephalopathy and animal welfare. He has also worked in general veterinary practice and for Government veterinary services in Belize and Yemen. He said: "I am delighted to have been appointed to this important and challenging role. I intend to build on the successes and lessons learned from recent exotic disease outbreaks to ensure that these risks continue to be managed as effectively as possible. "Defra and its Agencies must continue to work with animal keepers and the veterinary profession to deal with existing challenges such as Bluetongue and Tuberculosis, and to maintain good animal welfare standards and surveillance to identify and deal with any new threats. The Government will increasingly develop policy on disease control in partnership with key stakeholders and I am committed to ensuring that those decisions are founded on the best possible veterinary advice." Nigel's first event as CVO will be to represent the UK at the World Animal Health Organisation General Session in Paris from 25 to 30 May.
The Royal College of Veterinary Surgeons is stressing the need for employers to check the registration status of the veterinary surgeons and veterinary nurses they recruit.
This comes following several incidences where veterinary surgeons have been found to be either not registered or registered in the wrong category. For example, foreign nationals wishing to work in the UK must be registered as home-practising members, not overseas-practising members. The latter category is for those practising overseas who wish to retain their MRCVS status.
Furthermore, there have been some cases of veterinary surgeons registering as ‘non-practising' and going on to carry out veterinary nursing roles, in the absence of relevant qualifications or being listed/registered as a veterinary nurse. This may be happening in cases where overseas veterinary surgeons are struggling to find work in the UK, possibly due to language difficulties.
RCVS President Jill Nute said: "Vets and veterinary nurses have complementary roles within the practice team. If someone wishes to undertake a veterinary nursing role, they should be qualified and registered as such. Many skills are taught in the veterinary nursing training that are not included in the veterinary degree. Although some veterinary nursing tasks can be carried out by veterinary surgeons, they certainly must not be undertaken by those who are not on the RCVS Register of Veterinary Surgeons".
She added: "Ours is a self-regulated profession and it is important that employers play their part by ensuring that practice employees are appropriately qualified and registered".
The registration status of vets and veterinary nurses can be checked on RCVSonline at: www.rcvs.org.uk/checkregister or www.rcvs.org.uk/vnlist respectively.
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference:
Merial has announced the results of a survey which suggests that whilst diagnosis of gastric ulcers in horses is improving, there is still room for improvement.
The survey of 50 equine vets, which was conducted in May this year, showed that the number of practices owning a scope has more than doubled over the past six years. Half of equine practices now own a scope. Over the same period the average number of monthly scopes has risen from 1.5 to 9.25 and referrals from practices without a scope has risen by 65%.
Merial's Louise Radford MRCVS said: "The survey also showed that symptom recognition among vets prompting the need for an endoscopy has also risen. The vast majority of vets now consider changes in behaviour, loss of appetite and poor performance as potential signs. In addition, 100% of those surveyed would consider an endoscopy when presented with the signs of recurring colic.
"However whilst this is great progress, when diagnosis is compared to the incidence of ulcer, we know that more needs to be done. It is believed that up to 30% of leisure horses have some degree of gastric ulceration, and this increases in sports horses, yet just a fraction of this figure represents those scoped."
Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine at B&W Equine Hospital says he is pleased that more horses are being scoped for gastric ulcers but says that further education is needed: "We've seen a huge leap in the appreciation of the incidence of gastric ulceration in non-racing animals, which long term will better our understanding of the individual clinical relevance of particular lesions, and the benefits of treatment and management change.
"This should improve both performance and horse welfare, as well as increasing client satisfaction. Despite the huge increase in the diagnosis and treatment of equine gastric ulcers it is still believed that many horses go undiagnosed."
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
The VET Festival has announced its speaker line-up for this year's event, taking place on the 3rd & 4th June at Loseley Park in Guildford, Surrey.
The 21 hand-picked speakers include respected opinion formers from across the USA, Canada and the UK who are veterinary specialists and experts in fields including clinical & surgical orthopaedics, soft tissue surgery, medical & surgical oncology, neurology & neurosurgery, minimally invasive surgery & diagnostics, anaesthesia, diagnostic imaging, physiotherapy, sports medicine & rehabilitation, anaesthesia & critical care, nutrition, feline medicine & surgery and practice management & team building.
The organisers say this is a unique and unrivalled opportunity to hear, learn and network with some of the greatest minds in the veterinary world at a dynamic and engaging two-day outdoor conference designed for veterinary surgeons, veterinary nurses, veterinary rehab practitioners, practice support staff, managers and allied veterinary professionals working in companion animal practice.
Internationally-based speakers not available on the usual speaker circuit for primary care clinicians, include:
The 2016 conference will also welcome thought leaders currently practicing here in the UK, including:
There will be a focus on minimally invasive diagnostics and surgery lead by Phillip Mayhew from the University of Davis California and Elise Robertson will talk about minimally invasive endoscopy techniques in cats whilst Michael Kowaleski from Tufts University, Boston, and Noel Fitzpatrick will talk about arthroscopy of joints. There will also be a specific focus on diagnostic imaging with Russell Tucker from Washington State University sharing his nearly 40 years of experience with radiography, MRI and CT. Cancer is a huge area of increased interest in small animal practice currently and will be explored by a world-class team including Julius Liptak, Nick Bacon and Laurent Findji.
The growing importance of practice management and team-building prompted organisers to ask Brian Faulkner from the UK and Ernie Ward from the USA, both internationally recognised leaders in veterinary business training, to set up a mini-symposium in management and motivation. The objective is to keep the lectures practical and give delegates information that they can use every day, not just facts and figures.
Unlike conventional conferences, the VET Festival is staged outdoors in marquees alongside festival food and drinks and companies and organisations showcasing new technologies and products. Organisers say that this unique ‘fresh air’ festival environment creates a relaxed and fun atmosphere which is more conducive to learning and networking. There will be live music on both nights of the Festival with multiple bands contributing to the festival atmosphere, culminating in the ONE LIVE music concert on the final night.
For more information and to register for an early bird delegate discount visit www.vetfestival.co.uk
The Veterinary Marketing Association has 10 tickets available for its annual debate being held at the House of Lords on Tuesday October 12th, this year entitled: Internet Pharmacies - Opportunity or Threat?
The debate will be chaired by Professor Sandy Trees, and the panel will comprise:
The debate kicks off at 10:30am, and is followed by lunch at 12:30pm on the famous terrace, overlooking the Thames.
VetSurgeon members may buy tickets at the lower VMA member price of £120 + VAT, which includes the champagne reception and three course lunch with wine.
Click here for more information.
Zoetis has launched a new high precision treatment gun for single-handed low volume subcutaneous injections.
The gun handles medications up to 5ml per treatment. The company says it is designed for use with its long acting moxidectin injectable wormer and clostridial vaccines specifically, but is also suitable to other low dose medications administered subcutaneously
Zoetis vet Dave Armstrong said: "One-handed operation enables quicker treatment, better sheep welfare as a result of eliminating needle bending or breakage, and lower risk of self-injection by the operator."
As an indication of operator risk, Zoetis points to a report from one staff nurse working just 30-hours a week at a West Midlands hospital's A&E department, who dealt with three incidents of wormer self-injection in 20141.
Single-handed operation is made possible by a serrated needle guard that creates a skin fold into which the needle penetrates. Mr Armstrong says development of the gun is part of Zoetis's commitment - "as much as necessary, as little as possible" - towards helping farmers strengthen their effective and responsible use of animal medicines. He emphasises that for precision medicines to be exploited fully and responsibly, precision instrumentation is essential.
To accompany the gun, two detailed advisory booklets covering treatment techniques and equipment maintenance have also been published, covering a number of different designs including different volume injectors, pour-on applications and drenching guns. Copies are available free of charge to farmers from POM VPS medicine suppliers.
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
Intervet/Schering-Plough has launched Vectin chewable tablets, an ivermectin wormer for horses which is administered as a treat straight from the hand rather than in the traditional paste or granule formulation.
According to the company, syringe handling, horse acceptance and the tendency to spit out some or all of the paste are common problems reported by owners when worming their horses, and more than 55% admit that these issues can result in a mixture of emotions, including frustration, anxiety and upset.
Field studies with Vectin showed more than 70% spontaneous acceptance by horses and the simple calculation of one tablet for every 110kg of a horse or foal's bodyweight helps to reduce wastage as unused tablets can be stored away for future use.
Pharmacokinetics studies have demonstrated improved bioavailability (AUC) and maximal concentration (Cmax) when compared with an equivalent competitor ivermectin paste formulation. Trials have also shown that a more consistent blood concentration of ivermectin when given as a chew which could potentially limit the chance of inducing resistance.
Intervet/Schering Plough says that used as part of a strategic worming plan, Vectin chewable tablets control potentially a wide range of endoparasites including small and large strongyles, stomach worms, cutaneous worms and stomach bots.
Vectin chewable tablets are available as a seven-tablet blister pack, perfect for treating a horse or a couple of ponies. For yards, a tub of 60 tablets is available, containing enough to dispense product for worming approximately 12 horses.
Vectin chewable tablets are recommended for use alongside Pyratape P and Panacur in Intervet/Schering-Plough Animal Health's Active3 worming plan, a strategic three-year approach to rotating wormers in order to minimize the risk of resistance developing. Visit http://www.intervet.co.uk/ for a copy of the three-year plan.